| Literature DB >> 11832204 |
Abstract
Genetically engineered mouse models have contributed extensively to the field of cancer research. The ability to manipulate the mouse germline affords numerous approaches toward understanding the complexities of this disease, possibly providing accurate preclinical models for therapeutic and diagnostic advances. This review highlights some of the current strategies for modeling cancer in the mouse, recent accomplishments, and key remaining challenges.Entities:
Mesh:
Year: 2002 PMID: 11832204 DOI: 10.1016/s0092-8674(02)00621-9
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582